New research highlights sustained risk factors for ketoacidosis in type 2 diabetes patients on SGLT2 inhibitors

A Scandinavian registry study reveals that certain high-risk groups, such as those with high blood glucose, low body weight, or prior ketoacidosis episodes, face persistent risks of severe ketoacidosis while using SGLT2 inhibitors, prompting calls for improved patient screening and…













